Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.

Ying Liu; Yi Liu; Zai-Wen Fan; Jian Li; Guo-Gang Xu

首页> 外文期刊>European journal of clinical pharmacology >Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.

【24h】

Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.

机译：接受vandetanib治疗的晚期非小细胞肺癌患者高血压和QTc延长风险的荟萃分析。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Current evidence showed that significant risks in developing hypertension and QTc prolongation exist in advanced NSCLC patients who were receiving vandetanib. Thus, appropriate monitoring and management of these events are recommended.

机译：目前的证据表明，接受vandetanib治疗的晚期NSCLC患者存在发生高血压和QTc延长的重大风险。因此，建议对这些事件进行适当的监视和管理。

著录项

来源
《European journal of clinical pharmacology 》 |2015年第5期| 共7页
作者
Ying Liu; Yi Liu; Zai-Wen Fan; Jian Li; Guo-Gang Xu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib. [J] . Ying Liu, Yi Liu, Zai-Wen Fan, European journal of clinical pharmacology . 2015 ,第5期

机译：接受vandetanib治疗的晚期非小细胞肺癌患者高血压和QTc延长风险的荟萃分析。
2. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: A pooled analysis based on 39 reports [J] . XuT.-P., ShenH., LiuL.-X., Gene: An International Journal Focusing on Gene Cloning and Gene Structure and Function . 2013 ,第2期

机译：ERCC1-C118T和-C8092A多态性与肺癌风险和肺癌患者患者的肺癌危险和存活率接受铂类化疗：基于39报告的汇总分析
3. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: A pooled analysis based on 39 reports [J] . XuT.-P., ShenH., LiuL.-X., Gene: An International Journal Focusing on Gene Cloning and Gene Structure and Function . 2013 ,第2期

机译：ERCC1-C118T和-C8092A多态性与肺癌风险和肺癌患者患者的肺癌危险和存活率接受铂类化疗：基于39报告的汇总分析
4. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors [O] . Liping Lin, Juanjuan Zhao, Ning Kong, 2017

机译：用ALK抑制剂治疗的非小细胞肺癌患者间质性肺疾病和QTc延长的发生率和风险的荟萃分析
7. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study [O] . Koichi Takayama, Shinji Atagi, Fumio Imamura, 2016

机译：晚期非小细胞肺癌患者恶病质生活与生存质量调查-日本对晚期非小细胞肺癌患者营养和QOL的研究

Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib.

摘要

著录项

相似文献

相关主题

期刊订阅